{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:51:22Z","timestamp":1789800682192,"version":"4.0.1"},"reference-count":185,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Assisted reproductive technologies (ARTs) involve the laboratory manipulation of gametes and embryos to help couples with fertility problems become pregnant. One of these procedures, controlled ovarian stimulation, uses pharmacological agents to induce ovarian and follicular maturation in vivo. Despite the effectiveness in achieving pregnancy and live births, some patients may have complications due to over-response to gonadotropins and develop ovarian hyperstimulation syndrome. In vitro maturation (IVM) of oocytes has emerged as a technique to reduce the risk of ovarian hyperstimulation syndrome, particularly in women with polycystic ovary syndrome, and for fertility preservation in women undergoing oncological treatment. Although there are some limitations, primarily due to oocyte quality, recent advances have improved pregnancy success rates and neonatal and infant outcomes. Different terms have been coined to describe variations of IVM, and the technique has evolved with the introduction of hormones to optimize results. In this review, we provide a comprehensive overview of IVM relating hormonal priming, culture system and media, and clinical indications for IVM with its reproductive outcomes during ARTs.<\/jats:p>","DOI":"10.1093\/biolre\/ioae147","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T17:55:30Z","timestamp":1729274130000},"page":"18-30","source":"Crossref","is-referenced-by-count":13,"title":["In vitro maturation of oocytes: what is already known?"],"prefix":"10.1093","volume":"112","author":[{"given":"Ana Luiza Camargos","family":"Morato","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics , Ribeirao Preto Medical School, , Ribeirao Preto ,","place":["Brazil"]},{"name":"University of Sao Paulo , Ribeirao Preto Medical School, , Ribeirao Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Gennari","family":"Verruma","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics , Ribeirao Preto Medical School, , Ribeirao Preto ,","place":["Brazil"]},{"name":"University of Sao Paulo , Ribeirao Preto Medical School, , Ribeirao Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana Libardi Miranda","family":"Furtado","sequence":"additional","affiliation":[{"name":"Graduate Program in Medical Science , Experimental Biology Center, , Fortaleza ,","place":["Brazil"]},{"name":"University of Fortaleza , Experimental Biology Center, , Fortaleza ,","place":["Brazil"]},{"name":"Postgraduate Program in Translational Medicine , Drug Research and Development Center, , Fortaleza ,","place":["Brazil"]},{"name":"Federal University of Cear\u00e1 , Drug Research and Development Center, , Fortaleza ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Maria","family":"dos Reis","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics , Ribeirao Preto Medical School, , Ribeirao Preto ,","place":["Brazil"]},{"name":"University of Sao Paulo , Ribeirao Preto Medical School, , Ribeirao Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"2025011610383542900_ref1","volume-title":"StatPearls","author":"Jain","year":"2023"},{"key":"2025011610383542900_ref2","volume-title":"Assisted Reproductive Technology Fertility Clinic Success Rates Report","author":"Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology","year":"2019"},{"key":"2025011610383542900_ref3","first-page":"185","article-title":"Chapter 12 - assisted reproductive techniques","volume":"1","author":"Amjad","year":"2021","journal-title":"Subfertility: Recent Advances in Management and Prevention"},{"key":"2025011610383542900_ref4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/dmcn.15332","article-title":"Assisted reproductive technology: short- and long-term outcomes","volume":"65","author":"Graham","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"2025011610383542900_ref5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/196446a0","article-title":"Meiosis in ovarian oocytes of adult mammals","volume":"196","author":"Edwards","year":"1962","journal-title":"Nature"},{"key":"2025011610383542900_ref6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/humrep\/dew109","article-title":"Clinical definition paper on in vitro maturation of human oocytes","volume":"31","author":"Dahan","year":"2016","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/14647273.2021.1876932","article-title":"In vitro rescue immature oocytes - a literature review","volume":"25","author":"Jie","year":"2022","journal-title":"Hum Fertil"},{"key":"2025011610383542900_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.1994.1175","article-title":"Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes","volume":"164","author":"Eppig","year":"1994","journal-title":"Dev Biol"},{"key":"2025011610383542900_ref9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/humupd\/dmv011","article-title":"Oocyte maturation: gamete-somatic cells interactions, meiotic resumption, cytoskeletal dynamics and cytoplasmic reorganization","volume":"21","author":"Coticchio","year":"2015","journal-title":"Hum Reprod Update"},{"key":"2025011610383542900_ref10","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/humrep\/des200","article-title":"The oocyte","volume":"27","author":"Rienzi","year":"2012","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12958-023-01161-y","article-title":"Nuclear-cytoplasmic asynchrony in oocyte maturation caused by TUBB8 variants via impairing microtubule function: a novel pathogenic mechanism","volume":"21","author":"Chang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"2025011610383542900_ref12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.theriogenology.2006.09.027","article-title":"Oocyte maturation: emerging concepts and technologies to improve developmental potential in vitro","volume":"67","author":"Gilchrist","year":"2007","journal-title":"Theriogenology"},{"key":"2025011610383542900_ref13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/rep.0.1210051","article-title":"Maturation of human oocytes in vitro and their developmental competence","volume":"121","author":"Trounson","year":"2001","journal-title":"Reproduction"},{"key":"2025011610383542900_ref14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1071\/RD9960485","article-title":"Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals","volume":"8","author":"Eppig","year":"1996","journal-title":"Reprod Fertil Dev"},{"key":"2025011610383542900_ref15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12958-023-01162-x","article-title":"In vitro maturation (IVM) of human immature oocytes: is it still relevant?","volume":"21","author":"Das","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"2025011610383542900_ref16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/208349a0","article-title":"Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes","volume":"208","author":"Edwards","year":"1965","journal-title":"Nature"},{"key":"2025011610383542900_ref17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/biolreprod\/3.3.298","article-title":"In vitro development of mouse oocytes","volume":"3","author":"Cross","year":"1970","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1071\/RD99001","article-title":"In vitro maturation and in vitro fertilization of bovine oocytes cultured in a chemically defined, protein-free medium: effects of carbohydrates and amino acids","volume":"11","author":"Lim","year":"1999","journal-title":"Reprod Fertil Dev"},{"key":"2025011610383542900_ref19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.fertnstert.2023.02.010","article-title":"Oocyte in vitro maturation: physiological basis and application to clinical practice","volume":"119","author":"Gilchrist","year":"2023","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.fertnstert.2020.11.018","article-title":"In vitro maturation: a committee opinion","volume":"115","author":"Practice Committees of the American Society for Reproductive Medicine, the Society of Reproductive Biologists and Technologists, and the Society for Assisted Reproductive Technology","year":"2021","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref21","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/dew208","article-title":"The definition of IVM is clear variations need defining","volume":"31","author":"De Vos","year":"2016","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/biolre\/ioac010","article-title":"Present state and future outlook for the application of in vitro oocyte maturation in human infertility treatment","volume":"106","author":"Krisher","year":"2022","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref23","doi-asserted-by":"crossref","first-page":"024","DOI":"10.1055\/s-0030-1268701","article-title":"The promise of in vitro maturation in assisted reproduction and fertility preservation","volume":"29","author":"Smitz","year":"2011","journal-title":"Semin Reprod Med"},{"key":"2025011610383542900_ref24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4274\/tjod.23911","article-title":"Oocyte in vitro maturation: a systematic review","volume":"15","author":"Hat\u0131rnaz","year":"2018","journal-title":"Turk J Obstet Gynecol"},{"key":"2025011610383542900_ref25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3389\/fcell.2021.667682","article-title":"Age-dependent in vitro maturation efficacy of human oocytes - is there an optimal age?","volume":"9","author":"Karavani","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025011610383542900_ref26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/2096-2924.325827","article-title":"Research progress of in vitro oocyte maturation","volume":"5","author":"Jing","year":"2021","journal-title":"Reprod Dev Med"},{"key":"2025011610383542900_ref27","first-page":"1909","article-title":"Recent advances in InVitro maturation (IVM): a systematic literature review","volume":"03","author":"Amansyah","year":"2023","journal-title":"Int J Med Sci"},{"key":"2025011610383542900_ref28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.fertnstert.2023.01.027","article-title":"Future potential of in vitro maturation including fertility preservation","volume":"119","author":"Cadenas","year":"2023","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10815-011-9561-5","article-title":"Health of IVM children","volume":"28","author":"Basatemur","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref30","first-page":"77","article-title":"IVM results are comparable and may have advantages over standard IVF","volume":"6","author":"Ellenbogen","year":"2014","journal-title":"Facts Views Vis Obgyn"},{"key":"2025011610383542900_ref31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10815-019-01677-6","article-title":"Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome","volume":"37","author":"Vuong","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref32","doi-asserted-by":"crossref","first-page":"1047571","DOI":"10.3389\/fendo.2022.1047571","article-title":"Rescue in vitro maturation may increase the pregnancy outcomes among women undergoing intracytoplasmic sperm injection","volume":"13","author":"Qin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref33","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/humrep\/deac115","article-title":"Development of children born from IVM versus IVF: 2-year follow-up of a randomized controlled trial","volume":"37","author":"Vuong","year":"2022","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/reprodmed4010008","article-title":"The effect of in vitro maturation (IVM) protocol changes on measures of oocyte\/embryo competence","volume":"4","author":"Rose","year":"2023","journal-title":"Reprod Med"},{"key":"2025011610383542900_ref35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.62.5.665","article-title":"The comparative behavior of mammalian eggs in vivo and in vitro","volume":"62","author":"Pincus","year":"1935","journal-title":"J Exp Med"},{"key":"2025011610383542900_ref36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0002-9378(15)32963-X","article-title":"In vitro fertilization and cleavage of human ovarian eggs","volume":"55","author":"Rock","year":"1948","journal-title":"Am J Obstet Gynecol"},{"key":"2025011610383542900_ref37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/200281b0","article-title":"Fertilization of hamster eggs in vitro","volume":"200","author":"Yanagimachi","year":"1963","journal-title":"Nature"},{"key":"2025011610383542900_ref38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/220592a0","article-title":"Fertilization of mouse eggs in vitro","volume":"220","author":"Whittingham","year":"1968","journal-title":"Nature"},{"key":"2025011610383542900_ref39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/221632a0","article-title":"Early stages of fertilization in vitro of human oocytes matured in vitro","volume":"221","author":"Edwards","year":"1969","journal-title":"Nature"},{"key":"2025011610383542900_ref40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.rigp.2004.04.003","article-title":"History of assisted reproduction: lessons learnt and future challenges","volume":"4","author":"Passos","year":"2004","journal-title":"Rev Gynecol Pract"},{"key":"2025011610383542900_ref41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/molehr\/gat075","article-title":"Pioneering contributions by Robert Edwards to oocyte in vitro maturation (IVM)","volume":"19","author":"Thompson","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"2025011610383542900_ref42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","article-title":"Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program","volume":"55","author":"Cha","year":"1991","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0015-0282(16)56891-5","article-title":"In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients","volume":"62","author":"Trounson","year":"1994","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref44","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/oxfordjournals.humrep.a135896","article-title":"Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching","volume":"10","author":"Barnes","year":"1995","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2025011610383542900_ref46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/humupd\/4.2.103","article-title":"Maturation in vitro of immature human oocytes for clinical use","volume":"4","author":"Cha","year":"1998","journal-title":"Hum Reprod Update"},{"key":"2025011610383542900_ref47","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2012.06.055","article-title":"Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome","volume":"98","author":"Junk","year":"2012","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rbmo.2014.07.019","article-title":"In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome","volume":"29","author":"Das","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2025011610383542900_ref49","volume-title":"What is In Vitro Maturation (IVM)?","author":"American Society for Reproductive Medicine","year":"2014"},{"key":"2025011610383542900_ref50","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/humrep\/deg335","article-title":"Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes","volume":"18","author":"Lin","year":"2003","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0015-0282(99)00323-4","article-title":"Pregnancies resulting from in vitro matured oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin","volume":"72","author":"Chian","year":"1999","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13048-023-01294-z","article-title":"Cut-off point of mature oocyte for routine clinical application of rescue IVM: a retrospective cohort study","volume":"16","author":"Wei","year":"2023","journal-title":"J Ovarian Res"},{"key":"2025011610383542900_ref53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.rbmo.2018.08.023","article-title":"Do immature and mature sibling oocytes recovered from stimulated cycles have the same reproductive potential?","volume":"37","author":"Escrich","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2025011610383542900_ref54","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2018.05.019","article-title":"Let\u2019s rescue oocytes: in vitro maturation 2.0 is coming","volume":"110","author":"Escrich","year":"2018","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","article-title":"In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes","volume":"30","author":"Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref56","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s43032-021-00613-3","article-title":"The improvement and clinical application of human oocyte in vitro maturation (IVM)","volume":"29","author":"Gong","year":"2022","journal-title":"Reprod Sci"},{"key":"2025011610383542900_ref57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1071\/RD10225","article-title":"Recent insights into oocyte - follicle cell interactions provide opportunities for the development of new approaches to in vitro maturation","volume":"23","author":"Gilchrist","year":"2011","journal-title":"Reprod Fertil Dev"},{"key":"2025011610383542900_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmx029","article-title":"The epidermal growth factor network: role in oocyte growth, maturation and developmental competence","volume":"24","author":"Richani","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2025011610383542900_ref59","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/humrep\/dex262","article-title":"An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield","volume":"32","author":"S\u00e1nchez","year":"2017","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref60","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s10815-019-01551-5","article-title":"Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles","volume":"36","author":"Sanchez","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref61","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s10815-024-03143-4","article-title":"Rescue in vitro maturation using ovarian support cells of human oocytes from conventional stimulation cycles yields oocytes with improved nuclear maturation and transcriptomic resemblance to in vivo matured oocytes","volume":"41","author":"Paulsen","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref62","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/humupd\/dmq014","article-title":"Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries","volume":"16","author":"Son","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2025011610383542900_ref63","first-page":"1904","article-title":"Factors influencing the in vitro maturation (IVM) of human oocyte","volume":"9","author":"Yang","year":"2021","journal-title":"Biomedicine"},{"key":"2025011610383542900_ref64","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41598-022-06158-y","article-title":"The effects of temperature variation treatments on embryonic development: a mouse study","volume":"12","author":"Moriyama","year":"2022","journal-title":"Sci Rep"},{"key":"2025011610383542900_ref65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.fertnstert.2023.12.014","article-title":"Impact of oxygen tension during in vitro maturation: a sibling-oocyte prospective double-blinded study","volume":"121","author":"Boumerdassi","year":"2024","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref66","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10815-021-02263-5","article-title":"Perspectives on the development and future of oocyte IVM in clinical practice","volume":"38","author":"De Vos","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/jrf.0.0950119","article-title":"Developmental capacity of mouse oocytes matured in vitro: effects of gonadotrophic stimulation, follicular origin and oocyte size","volume":"95","author":"Eppig","year":"1992","journal-title":"J Reprod Fertil"},{"key":"2025011610383542900_ref68","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1095\/biolreprod56.1.238","article-title":"Maturation, fertilization, and development of marmoset monkey oocytes in vitro","volume":"56","author":"Gilchrist","year":"1997","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref69","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/humrep\/den210","article-title":"A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles","volume":"23","author":"Son","year":"2008","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2006.09.016","article-title":"Is human chorionic gonadotropin directly involved in the regulation of human implantation?","volume":"269","author":"Licht","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"2025011610383542900_ref71","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humrep\/dev325","article-title":"Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients","volume":"31","author":"Grynberg","year":"2016","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10815-011-9575-z","article-title":"Controversies in IVM","volume":"28","author":"Reinblatt","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2012.07.001","article-title":"PCOS patients can benefit from in vitro maturation (IVM) of oocytes","volume":"165","author":"Shalom-Paz","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025011610383542900_ref74","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.fertnstert.2013.06.018","article-title":"A \u201cfreeze-all\u201d embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?","volume":"100","author":"Ortega-Hrepich","year":"2013","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref75","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.fertnstert.2013.01.148","article-title":"Estrogen-suppressed in vitro maturation: a novel approach to in vitro maturation","volume":"99","author":"Vitek","year":"2013","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref76","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1472-6483(10)61438-1","article-title":"Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS","volume":"13","author":"Son","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2025011610383542900_ref77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.fertnstert.2007.02.021","article-title":"Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome","volume":"89","author":"Ge","year":"2008","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref78","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/humrep\/17.4.1006","article-title":"Assessment of nuclear and cytoplasmic maturation in in-vitro matured human oocytes","volume":"17","author":"Combelles","year":"2002","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref79","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10815-015-0528-9","article-title":"In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising \"ex vivo\" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe","volume":"32","author":"Segers","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1095\/biolreprod57.1.49","article-title":"Synchronization of meiosis in porcine oocytes by exposure to dibutyryl cyclic adenosine monophosphate improves developmental competence following in vitro fertilization","volume":"57","author":"Funahashi","year":"1997","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref81","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1095\/biolreprod.103.021105","article-title":"Effect of phosphodiesterase type 3 inhibitor on developmental competence of immature mouse oocytes in vitro","volume":"69","author":"Nogueira","year":"2003","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref82","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1095\/biolreprod.103.024828","article-title":"Effect of specific phosphodiesterase isoenzyme inhibitors during in vitro maturation of bovine oocytes on meiotic and developmental capacity","volume":"71","author":"Thomas","year":"2004","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1095\/biolreprod.114.118869","article-title":"Natriuretic peptide precursor C delays meiotic resumption and sustains gap junction-mediated communication in bovine cumulus-enclosed oocytes","volume":"91","author":"Franciosi","year":"2014","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref84","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/REP-15-0606","article-title":"Oocyte maturation and quality: role of cyclic nucleotides","volume":"152","author":"Gilchrist","year":"2016","journal-title":"Reproduction"},{"key":"2025011610383542900_ref85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fendo.2020.00279","article-title":"Human chorionic gonadotropin priming does not improve pregnancy outcomes of PCOS-IVM cycles","volume":"11","author":"Lin","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref86","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/humrep\/13.11.3132","article-title":"Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation","volume":"13","author":"Wynn","year":"1998","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000367660","article-title":"Outcomes of follicle-stimulating hormone priming and nonpriming in in vitro maturation of oocytes in infertile women with polycystic ovarian syndrome: a single-blinded randomized study","volume":"79","author":"Choavaratana","year":"2015","journal-title":"Gynecol Obstet Invest"},{"key":"2025011610383542900_ref88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13048-018-0445-5","article-title":"Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome","volume":"11","author":"Ho","year":"2018","journal-title":"J Ovarian Res"},{"key":"2025011610383542900_ref89","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10815-023-02752-9","article-title":"Cumulative live birth rate after oocyte in vitro maturation with a pre-maturation step in women with polycystic ovary syndrome or high antral follicle count","volume":"40","author":"Pham","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref90","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/humrep\/deaa240","article-title":"In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref91","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/deae108.980","article-title":"Cumulative live birth rate after use of capacitation in vitro maturation in women with predicted excessive response to ovarian stimulation: an analysis of 1,563 cycles","volume":"39","author":"Ho","year":"2024","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref92","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1098-2795(199909)54:1<86::AID-MRD13>3.0.CO;2-C","article-title":"Effect of different levels of intracellular cAMP on the in vitro maturation of cattle oocytes and their subsequent development following in vitro fertilization","volume":"54","author":"Luciano","year":"1999","journal-title":"Mol Reprod Dev"},{"key":"2025011610383542900_ref93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.fertnstert.2007.03.090","article-title":"Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation","volume":"89","author":"Huang","year":"2008","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1095\/biolreprod.116.139808","article-title":"Immature oocytes from unprimed juvenile mice become a valuable source for embryo production when using C-type natriuretic peptide as essential component of culture medium","volume":"95","author":"Romero","year":"2016","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1142\/S2661318222740097","article-title":"The science of IVM","volume":"04","author":"Gilchrist","year":"2022","journal-title":"Fertility Reprod"},{"key":"2025011610383542900_ref96","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10815-021-02118-z","article-title":"Improved maturation competence of ovarian tissue oocytes using a biphasic in vitro maturation system for patients with gynecological malignancy: a study on sibling oocytes","volume":"38","author":"Kirillova","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.fertnstert.2007.11.082","article-title":"Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human tubal fluid","volume":"91","author":"De Araujo","year":"2009","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref98","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.fertnstert.2010.10.035","article-title":"Comparison of in vitro maturation media of immature oocytes: the effectiveness of blastocyst culture media","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref99","doi-asserted-by":"crossref","first-page":"e12601","DOI":"10.1111\/jpi.12601","article-title":"Melatonin promotes human oocyte maturation and early embryo development by enhancing clathrin-mediated endocytosis","volume":"67","author":"Li","year":"2019","journal-title":"J Pineal Res"},{"key":"2025011610383542900_ref100","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.fertnstert.2009.04.007","article-title":"Brain-derived neurotrophic factor is a regulator of human oocyte maturation and early embryo development","volume":"93","author":"Anderson","year":"2010","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref101","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3892\/mmr.2017.6742","article-title":"Gene expression profiling of human blastocysts from in vivo and 'rescue IVM' with or without melatonin treatment","volume":"16","author":"Hao","year":"2017","journal-title":"Mol Med Rep"},{"key":"2025011610383542900_ref102","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.fertnstert.2018.01.020","article-title":"Resveratrol improves in vitro maturation of oocytes in aged mice and humans","volume":"109","author":"Liu","year":"2018","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref103","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/humrep\/dey006","article-title":"High-glucose concentrations change DNA methylation levels in human IVM oocytes","volume":"33","author":"Wang","year":"2018","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref104","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41419-020-03183-5","article-title":"Quercetin promotes in vitro maturation of oocytes from humans and aged mice","volume":"11","author":"Cao","year":"2020","journal-title":"Cell Death Dis"},{"key":"2025011610383542900_ref105","first-page":"136","article-title":"Comparison of Medicult and Sage Media for in vitro maturation of immature oocytes obtained during cesarean deliveries","volume":"3","author":"Pongsuthirak","year":"2015","journal-title":"JFIV Reprod Med Genet"},{"key":"2025011610383542900_ref106","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1472-6483(10)60582-2","article-title":"Retrospective comparison of two media for invitro maturation of oocytes","volume":"16","author":"Filali","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2025011610383542900_ref107","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1933719114542027","article-title":"Comparison of blastocyst and Sage media for in vitro maturation of human immature oocytes","volume":"22","author":"Pongsuthirak","year":"2015","journal-title":"Reprod Sci"},{"key":"2025011610383542900_ref108","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mefs.2017.03.002","article-title":"Comparing the effects of different in vitro maturation media on IVM outcomes of MI oocytes","volume":"22","author":"Fesahat","year":"2017","journal-title":"Middle East Fertil Soc J"},{"key":"2025011610383542900_ref109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5653\/cerm.2017.44.2.79","article-title":"The effects of different types of media on in vitro maturation outcomes of human germinal vesicle oocytes retrieved in intracytoplasmic sperm injection cycles","volume":"44","author":"Fesahat","year":"2017","journal-title":"Clin Exp Reprod Med"},{"key":"2025011610383542900_ref110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.fertnstert.2007.02.052","article-title":"Influence of well defined protein source on in vitro maturation of human oocyte: human follicular fluid versus human serum albumin","volume":"89","author":"Jee","year":"2008","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref111","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fendo.2019.00485","article-title":"Growth hormone promotes in vitro maturation of human oocytes","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref112","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5653\/cerm.2019.00402","article-title":"Growth differentiation factor 9 and cumulus cell supplementation in in vitro maturation culture media enhances the viability of human blastocysts","volume":"46","author":"Chatroudi","year":"2019","journal-title":"Clin Exp Reprod Med"},{"key":"2025011610383542900_ref113","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/humrep\/des099","article-title":"Effects of combined epidermal growth factor, brain-derived neurotrophic factor and insulin-like growth factor-1 on human oocyte maturation and early fertilized and cloned embryo development","volume":"27","author":"Yu","year":"2012","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref114","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.rbmo.2018.01.011","article-title":"Human oocyte maturation in vitro is improved by co-culture with cumulus cells from mature oocytes","volume":"36","author":"Virant-Klun","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2025011610383542900_ref115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.fertnstert.2020.04.002","article-title":"Coenzyme Q10 supplementation of human oocyte in vitro maturation reduces postmeiotic aneuploidies","volume":"114","author":"Ma","year":"2020","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref116","doi-asserted-by":"crossref","first-page":"1040503","DOI":"10.3389\/fendo.2022.1040503","article-title":"Growth hormone in fertility and infertility: mechanisms of action and clinical applications","volume":"13","author":"Chang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref117","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/2230-8210.84876","article-title":"Growth hormone in the management of female infertility","volume":"15","author":"Magon","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"2025011610383542900_ref118","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00404-016-4163-1","article-title":"Growth hormone co-treatment within a GnRH agonist long protocol improves implantation and pregnancy rates in patients undergoing IVF-ET","volume":"294","author":"Du","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"2025011610383542900_ref119","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged &gt;40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","article-title":"Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial","volume":"25","author":"Kucuk","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref121","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60011-9","article-title":"Effect of growth hormone on oocyte competence in patients with multiple IVF failures","volume":"18","author":"Hazout","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2025011610383542900_ref122","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial","volume":"105","author":"Bassiouny","year":"2016","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09513590.2017.1399693","article-title":"Growth hormone co-treatment in IVF\/ICSI cycles in poor responders","volume":"33","author":"Ob'edkova","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2025011610383542900_ref124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0303-7207(94)90204-6","article-title":"Growth hormone induces in vitro maturation of follicle- and cumulus-enclosed rat oocytes","volume":"106","author":"Apa","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"2025011610383542900_ref125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1098-2795(199611)45:3<372::AID-MRD15>3.0.CO;2-0","article-title":"In vitro maturation of bovine oocytes in the presence of growth hormone accelerates nuclear maturation and promotes subsequent embryonic development","volume":"45","author":"Izadyar","year":"1996","journal-title":"Mol Reprod Dev"},{"key":"2025011610383542900_ref126","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/(SICI)1098-2795(199804)49:4<444::AID-MRD12>3.0.CO;2-U","article-title":"The promotory effect of growth hormone on the developmental competence of in vitro matured bovine oocytes is due to improved cytoplasmic maturation","volume":"49","author":"Izadyar","year":"1998","journal-title":"Mol Reprod Dev"},{"key":"2025011610383542900_ref127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0303-7207(02)00270-8","article-title":"Role of growth hormone and growth hormone receptor in oocyte maturation","volume":"197","author":"Bevers","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2025011610383542900_ref128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1095\/biolreprod.103.015602","article-title":"Effect of growth hormone (GH) on in vitro nuclear and cytoplasmic oocyte maturation, cumulus expansion, hyaluronan synthases, and connexins 32 and 43 expression, and GH receptor messenger RNA expression in equine and porcine species","volume":"69","author":"Marchal","year":"2003","journal-title":"Biol Reprod"},{"key":"2025011610383542900_ref129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14310\/horm.2002.11153","article-title":"Effects of GH and IGF-I on the in vitro maturation of mouse oocytes","volume":"4","author":"Kiapekou","year":"2005","journal-title":"Hormones (Athens)"},{"key":"2025011610383542900_ref130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1439-0531.2004.00547.x","article-title":"Addition of recombinant human growth hormone to in vitro maturation medium of bovine oocytes","volume":"40","author":"Pozzobon","year":"2005","journal-title":"Reprod Domest Anim"},{"key":"2025011610383542900_ref131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10815-008-9208-3","article-title":"Growth hormone and in vitro maturation of rhesus macaque oocytes and subsequent embryo development","volume":"25","author":"De Prada","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref132","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1439-0531.2008.01290.x","article-title":"Effects of growth hormone on nuclear maturation of ovine oocytes and subsequent embryo development","volume":"45","author":"Shirazi","year":"2010","journal-title":"Reprod Domest Anim"},{"key":"2025011610383542900_ref133","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1016630603560","article-title":"Effects of growth hormone on in vitro maturation of germinal vesicle of human oocytes retrieved from small antral follicles","volume":"18","author":"Hassan","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref134","doi-asserted-by":"crossref","first-page":"1055097","DOI":"10.3389\/fendo.2022.1055097","article-title":"The role of growth hormone in assisted reproduction","volume":"13","author":"Quaas","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/humrep\/deab243","article-title":"In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial","volume":"37","author":"Zheng","year":"2022","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref136","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2023.05.163","article-title":"The developmental potential of mature oocytes derived from rescue in vitro maturation","volume":"120","author":"Shani","year":"2023","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref137","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/dez060","article-title":"The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count","volume":"34","author":"Ho","year":"2019","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref138","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/humrep\/dez086","article-title":"Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation","volume":"34","author":"Mostinckx","year":"2019","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref139","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.fertnstert.2019.05.034","article-title":"Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oocytes","volume":"112","author":"Yu","year":"2019","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref140","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.21037\/atm-21-3037","article-title":"Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis","volume":"9","author":"Xu","year":"2021","journal-title":"Ann Transl Med"},{"key":"2025011610383542900_ref141","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1093\/humrep\/des359","article-title":"Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles","volume":"27","author":"Fadini","year":"2012","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref142","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s10815-022-02559-0","article-title":"Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study","volume":"39","author":"Nguyen","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref143","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/humupd\/dmaa056","article-title":"Maternal and neonatal outcome and children\u2019s development after medically assisted reproduction with in-vitro matured oocytes-a systematic review and meta-analysis","volume":"27","author":"Strowitzki","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2025011610383542900_ref144","first-page":"571","article-title":"The case for in vitro maturation lower cost and more patient friendly","volume":"59","author":"Rose","year":"2014","journal-title":"J Reprod Med"},{"key":"2025011610383542900_ref145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5653\/cerm.2013.40.4.143","article-title":"In vitro maturation: clinical applications","volume":"40","author":"Lim","year":"2013","journal-title":"Clin Exp Reprod Med"},{"key":"2025011610383542900_ref146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5750298","article-title":"The place of in vitro maturation in PCO\/PCOS","volume":"2018","author":"Julania","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2025011610383542900_ref147","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bpobgyn.2018.06.004","article-title":"In vitro maturation","volume":"53","author":"Walls","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025011610383542900_ref148","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.fertnstert.2013.01.138","article-title":"Oocyte in vitro maturation in normo-ovulatory women","volume":"99","author":"Fadini","year":"2013","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref149","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2013.01.090","article-title":"In vitro maturation of oocytes: uncommon indications","volume":"99","author":"Grynberg","year":"2013","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/GCO.0000000000000942","article-title":"An update on the current indications for in vitro maturation","volume":"36","author":"Ho","year":"2024","journal-title":"Curr Opin Obstet Gyn"},{"key":"2025011610383542900_ref151","doi-asserted-by":"crossref","first-page":"e0227063","DOI":"10.1371\/journal.pone.0227063","article-title":"The delay of motherhood: reasons, determinants, time used to achieve pregnancy, and maternal anxiety level","volume":"14","author":"Molina-Garc\u00eda","year":"2019","journal-title":"PloS One"},{"key":"2025011610383542900_ref152","first-page":"e46291","article-title":"Exploring the complex landscape of delayed childbearing: factors, history, and long-term implications","volume":"15","author":"Zabak","year":"2023","journal-title":"Cureus"},{"key":"2025011610383542900_ref153","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025011610383542900_ref154","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025011610383542900_ref155","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025011610383542900_ref156","doi-asserted-by":"crossref","first-page":"2305082","DOI":"10.1080\/15592294.2024.2305082","article-title":"Resistance and aerobic training increases genome-wide DNA methylation in women with polycystic ovary syndrome","volume":"19","author":"Miranda Furtado","year":"2024","journal-title":"Epigenetics"},{"key":"2025011610383542900_ref157","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/15598276211001330","article-title":"Distinct protocols of physical exercise may improve different aspects of well-being in women with polycystic ovary syndrome","volume":"17","author":"Kogure","year":"2021","journal-title":"Am J Lifestyle Med"},{"key":"2025011610383542900_ref158","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jsxm.2018.09.002","article-title":"Comparison of the effect of intermittent and continuous aerobic physical training on sexual function of women with polycystic ovary syndrome: randomized controlled trial","volume":"15","author":"Lopes","year":"2018","journal-title":"J Sex Med"},{"key":"2025011610383542900_ref159","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00404-017-4561-z","article-title":"Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome","volume":"297","author":"Tannus","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2025011610383542900_ref160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.humrep.a138029","article-title":"A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization","volume":"8","author":"MacDougall","year":"1993","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref161","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(01)02853-9","article-title":"In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome","volume":"76","author":"Child","year":"2001","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref162","doi-asserted-by":"crossref","first-page":"1192180","DOI":"10.3389\/fendo.2023.1192180","article-title":"The spectrum of in vitro maturation in clinical practice: the current insight","volume":"14","author":"Ahmad","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref163","doi-asserted-by":"crossref","first-page":"e0134696","DOI":"10.1371\/journal.pone.0134696","article-title":"In vitro maturation in women with vs. without polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"10","author":"Siristatidis","year":"2015","journal-title":"PloS One"},{"key":"2025011610383542900_ref164","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0002-9378(16)34255-7","article-title":"A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus","volume":"104","author":"Jones","year":"1969","journal-title":"Am J Obstet Gynecol"},{"key":"2025011610383542900_ref165","doi-asserted-by":"crossref","first-page":"1030004","DOI":"10.3389\/fmed.2022.1030004","article-title":"Resistant ovary syndrome: pathogenesis and management strategies","volume":"9","author":"Mu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025011610383542900_ref166","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0015-0282(16)48200-2","article-title":"Endocrine and immunologic studies in a patient with resistant ovary syndrome","volume":"42","author":"Talbert","year":"1984","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref167","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2265.1999.00745.x","article-title":"Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome","volume":"51","author":"Conway","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025011610383542900_ref168","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s10815-018-1317-z","article-title":"In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation","volume":"35","author":"Galv\u00e3o","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref169","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10815-018-1394-z","article-title":"Successful in vitro maturation of oocytes in a woman with gonadotropin-resistant ovary syndrome associated with a novel combination of FSH receptor gene variants: a case report","volume":"36","author":"Flageole","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-1208.183514","article-title":"Poor ovarian reserve","volume":"9","author":"Jirge","year":"2016","journal-title":"J Hum Reprod Sci"},{"key":"2025011610383542900_ref171","first-page":"4","article-title":"The presence of immature GV\u2212 stage oocytes during IVF\/ICSI is a marker of poor oocyte quality: a pilot study","volume":"8","author":"Astbury","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"2025011610383542900_ref172","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5152\/jtgga.2013.68335","article-title":"In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: a case report","volume":"14","author":"Yal\u00e7\u0131nkaya","year":"2013","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"2025011610383542900_ref173","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12020-015-0744-1","article-title":"Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR)","volume":"52","author":"Lee","year":"2016","journal-title":"Endocrine"},{"key":"2025011610383542900_ref174","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s10815-021-02253-7","article-title":"Developmental potential of immature human oocytes aspirated after controlled ovarian stimulation","volume":"38","author":"Mandelbaum","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0015-0282(03)00665-4","article-title":"Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles","volume":"80","author":"Liu","year":"2003","journal-title":"Fertil Steril"},{"key":"2025011610383542900_ref176","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00520-024-08586-0","article-title":"Oocyte collection and outcome following oncologic treatment: a retrospective multicentre study","volume":"32","author":"Fern\u00e1ndez-Gonz\u00e1lez","year":"2024","journal-title":"Support Care Cancer"},{"key":"2025011610383542900_ref177","first-page":"126","article-title":"Suspected infertility after treatment for leukemia and solid tumors in childhood and adolescence","volume":"109","author":"Balcerek","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"2025011610383542900_ref178","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.3390\/ijms25084360","article-title":"Current fertility preservation steps in young women suffering from cancer and future perspectives","volume":"25","author":"Marco","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2025011610383542900_ref179","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.xfnr.2022.07.002","article-title":"In vitro maturation of oocytes for fertility preservation: a comprehensive review","volume":"3","author":"Grynberg","year":"2022","journal-title":"F&S Reviews"},{"key":"2025011610383542900_ref180","doi-asserted-by":"crossref","first-page":"e12524","DOI":"10.1002\/rmb2.12524","article-title":"IVM of human immature oocytes for infertility treatment and fertility preservation","volume":"22","author":"Chian","year":"2023","journal-title":"Reprod Med Biol"},{"key":"2025011610383542900_ref181","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fendo.2019.00464","article-title":"Immature oocyte for fertility preservation","volume":"10","author":"Son","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025011610383542900_ref182","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.annonc.2020.01.005","article-title":"First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer","volume":"31","author":"Grynberg","year":"2020","journal-title":"Ann Oncol"},{"key":"2025011610383542900_ref183","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/humrep\/deae108.717","article-title":"Ten years\u2019 experience using cryopreserved oocytes from in vitro maturation (IVM) or controlled ovarian hyperstimulation (COH) cycles for fertility preservation in oncologic indications","volume":"39","author":"Boumerdassi","year":"2024","journal-title":"Hum Reprod"},{"key":"2025011610383542900_ref184","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10815-018-1138-0","article-title":"Thirteen years\u2019 experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments","volume":"35","author":"Creux","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"2025011610383542900_ref185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2478\/raon-2021-0053","article-title":"In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program","volume":"56","author":"Virant-Klun","year":"2021","journal-title":"Radiol Oncol"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioae147\/60967332\/ioae147.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/112\/1\/18\/60967332\/ioae147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/112\/1\/18\/60967332\/ioae147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:39:40Z","timestamp":1737023980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/112\/1\/18\/7826682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,18]]},"published-print":{"date-parts":[[2025,1,14]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioae147","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,10,18]]}}}